期刊文献+

不对称二甲基精氨酸与蛛网膜下腔出血后脑血管痉挛的关系 被引量:2

Correlation between asymmetric dimethylarginine and cerebral vasospasm secondary to subarachnoid hemorrhage
原文传递
导出
摘要 目的 探讨蛛网膜下腔出血(SAH)后大鼠血、脑脊液不对称二甲基精氨酸(ADMA)的浓度变化及其与一氧化氮(NO)浓度和脑血管痉挛(CVS)的关系.方法 将78只SD大鼠分为对照组(n=6)、假手术组(n=36)及SAH组(n=36),采用枕大池二次注血法建立SAH动物模型.定期检测各亚组血浆、脑脊液中ADMA、NO浓度;显微镜下测量基底动脉壁厚度及动脉内径.结果 (1)SAH组脑脊液ADMA浓度逐渐升高,至术后5d达其最高值;NO浓度逐渐降低,至术后5d达其最低值;(2)以基底动脉壁厚度与内径的比值作为评价CVS程度的指标并进行Pearson相关性分析,SAH组脑脊液ADMA浓度与CVS程度呈正相关;与脑脊液NO浓度呈负相关.(3) SAH组血浆ADMA浓度无明显变化.结论 ADMA可能通过抑制NO生成影响SAH大鼠CVS的发生与发展;脑脊液ADMA水平与SAH大鼠CVS程度明显相关,可作为预测CVS的指标;血浆ADMA水平与CVS程度无明显相关. Objective To investigate the correlation between asymmetric dimethylarginine (ADMA) and cerebral vasospasm (CVS) secondary to subarachnoid hemorrhage (SAH).Methods Seventy-eight healthy male adult Sprague-Dawley rats were randomly allocated into control group (n =6),sham group (n =36) and SAH group (n =36).In SAH group,a SAH model was established by double autologous blood injection into cisterna magna.Arterial blood,cerebrospinal fluid (CSF) and basilar artery samples of each group were collected at the preconcerted time.ADMA levels in the plasma and CSF samples were assessed using enzyme-linked immuno sorbent assay (ELISA).Nitrite and nitrate concentrations were used as a marker of nitric oxide production in plasma and CSF samples and determined by using nitrate reductase method.Pathomorphological changes were observed with optical microscope and inner diameter of basilar artery was measured by Micrometer after hematoxylin-eosin staining was performed.Results (1) In SAH group,ADMA levels in CSF samples were significantly increased at 1st,3rd,5th and 7th day (P <0.05),and NO levels in CSF samples were significantly decreased at 3rd,5th,and 7th day as compared with sham group (P<0.01).(2) The ratio of thickness and inner diameter of basilar artery was used to indicate the degree of CVS.The level of ADMA in CSF samples was strongly correlated with the degree of CVS (r =0.641,P <0.01).Nitrite levels in CSF samples were negatively correlated with ADMA levels in CSF samples (r =-0.687,P <0.01).(3) Plasma ADMA levels in sham group and SAH group were similar and remained essentially unchanged during the several days after SAH.Plasma ADMA levels were neither correlated with NO levels (r =0.019,P > 0.05) nor with the degree of vasospasm (r =-0.046,P > 0.05).Conclusion Asymmetric dimethylarginine reduces the level of nitric oxide in CSF by inhibiting nitric oxide synthase and may be involved in the progression of cerebral vasospasm.The level of ADMA in CSF samples was strongly correlated with the degree of CVS in SAH rats.There is no evident correlation between the level of ADMA in plasma and the degree of CVS.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2013年第12期2618-2621,共4页 Chinese Journal of Experimental Surgery
基金 四川省医学重点建设科学基金资助项目[川卫办发(2007)407] 四川省教育厅科研资助课题项目(13ZB0237) 川北医学院科研发展计划项目(CBY12-A-ZD12)
关键词 蛛网膜下腔出血 脑血管痉挛 不对称二甲基精氨酸 一氧化氮 Subarachnoid hemorrhage Cerebral vasospasm Asymmetric dimethylarginine Nitric oxide
  • 相关文献

参考文献3

二级参考文献38

共引文献9

同被引文献21

  • 1Hirashima Y, Endo S, Kato R, et al. Prevention of cerebrovasospasm following subarachnoid hemorrhage in rabbits by the platelet-activa- ting factor antagonist, E5880 [ J ]. J Neurosurg, 1996,84 ( 5 ) : 826- 830.
  • 2Mori K, Yamamoto T, Miyazaki M, et al. Optimal eerebrospinal fluid magnesium ion concentration for vasodilatory effect and duration after intracisternal injection of magnesium sulfate solution in a eanine sub- arachnoid hemorrhage model [ J ]. J Neurosurg, 2011,114 ( 4 ) : 1168- 1175.
  • 3Bradford CM, Finfer S, O' Connor A, et al. A randomised controlled trial of induced hypermagnesaemia following aneurysmal subarachnoid haemorrhage[ J]. Crit Care Resusc,2013,15(2) :119-125.
  • 4Dorhout Mees SM, Algra A, Vandertop WP, et al. Magnesium for an- eurysmal subaraehnoid haemorrhage ( MASH-2 ) : a randomised place- bo-cantrelled trial[ J]. Lancet,2012,380 (9836) :44-49.
  • 5Wong GK, Boet R, Poon WS, et al. Intravenous magnesium sulphate for aneurysmal subarachnoid hemorrhage:an updated systemic review and meta-analysis [ J]. Crit Care,201 1, 15 ( 1 ): R52.
  • 6Westermaier T, Stetter C, Vince GH, et al. Prophylactic intravenous magnesium sulfate for treatment of aneurysmal subarachnoid hemor- rhage : a randomized, placebo-controlled, clinical study [ J ]. Crit Care Med,2010,38 (5) : 1284-1290.
  • 7Akdemir H, Kulaksizoglu O, Tucer B, et al. Magnesium sulfate ther- apy for cerebral vasospasm after aneurysmal subarachnoid hemorrhage [ J] . Neurosurg Q ,2009,19(1 ) :35 - 39.
  • 8Muroi C,Terzic A,Fortunati M,et al. Magnesium sulfate in the man- agement of patients with aneurysmal subarachnoid hemorrhage: a ran- domized, placebo-controlled, dose-adapted trial [ J ]. Surg Neurel, 2008,69( 1 ) :33-39.
  • 9Wong GK,Chan MT,Boet R,et al. Intravenous magnesium sulfate after aneurysmal subarachnoid hemorrhage: a prospective randomized pilot study[ J ]. J Nemosurg Anesthesio1,2006,18 (2) : 142-148.
  • 10van den Bergh WM, Algra A, van Kooten F, et al. Magnesium sulfate in aneurysmal subarachnoid hemorrhage:a randomized controlled trial [ J ]. Stroke ,2005,36 (5) : 1011-1015.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部